menpf-1
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2012 (NCT01640652)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Neisseria meningitidisImmunity, active
Neisseria meningitidis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- menpf-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01640652 | Phase 1 | Aug 1, 2012 | Government of Norway, University of Oxford, Wellcome Trust |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Norway | Government | 1 | 0 | 1 | 2012 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1